MGRX Stock Analysis: Buy, Sell, or Hold?
MGRX - Mangoceuticals, Inc. Common Stock
$0.40
-0.08 (-17.16%)
▼
5d:
+24.71%
30d:
-24.54%
90d:
-43.36%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 02, 2026
2d
Get Alerted When MGRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MGRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MGRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MGRX is currently trading at $0.40, which is considered extended relative to its 30-day fair value range of $0.32 to $0.49.
Technical Outlook: Technically, MGRX is in a strong downtrend. The price is approaching resistance at $0.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 17.2% recently.
Market Sentiment: MGRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MGRX is in a strong downtrend. The price is approaching resistance at $0.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 17.2% recently.
Market Sentiment: MGRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.32 -
$0.49
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-17.2%)
Fair Price Analysis
30-Day Fair Range
$0.32 -
$0.49
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.16
Resistance Level
$0.41
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Revenue Growth (YoY)
-36.8%
Share & Embed Analysis
Last updated: March 30, 2026 9:57 AM ET
Data refreshes hourly during market hours. Next update: 10:57 AM
Data refreshes hourly during market hours. Next update: 10:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Eugene M Johnston
SELL
3333 shares
2025-12-15
Eugene M Johnston
SELL
5000 shares
2025-12-09
Eugene M Johnston
SELL
10000 shares
2025-12-05
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 50 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 46 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 58 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 60 BUY |
